Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 6/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | FAAH | O00519 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2585105 | 0.89 | GABRA1 (0.68) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL29699645 | 0.89 | GABRA1 (0.68) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL9614891 | 0.84 | ADRB2 (0.39) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL24217828 | 0.82 | ADRB2 (0.42) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL30046916 | 0.82 | ADRB2 (0.42) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL25221643 | 0.82 | GABRA1 (0.54) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL2989000 | 0.82 | ADRB2 (0.42) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL11038353 | 0.80 | GABRA1 (0.52) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL6679675 | 0.80 | GABRA1 (0.52) | GABRA1GABRB2GABRB1LMNASLC6A2 | |
| SCHEMBL6015493 | 0.80 | GABRA1 (0.46) | GABRA1GABRB2GABRB1LMNASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12044968-B2 | Protective film-forming composition having acetal structure and amide structure | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12016312-B2 | Animal models, screening methods, and treatment methods for intraocular diseases or disorders | Smilebiotek Zhuhai Limited (CN) | 2024-06-25 | — | — | US | disclosed |
| WO-2022098879-A1 | SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME | AXIAL THERAPEUTICS, INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| US-20220133634-A1 | SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME | AXIAL THERAPEUTICS, INC. (US) | 2022-05-05 | — | — | US | disclosed |
| US-11236082-B2 | EZH2 inhibitors and uses thereof | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| US-20220015338-A1 | ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS | Smilebiotek Zhuhai Limited (CN) | 2022-01-20 | — | — | US | disclosed |
| US-11214715-B2 | Ionic polymers and their use as wet-adhesives and coatings | ACatechol, Inc. (US) | 2022-01-04 | — | — | US | disclosed |
| CN-113260921-A | Photosensitive resin composition, dry film, photosensitive dry film, resist film, substrate with mold, and method for producing plated molded article | 东京应化工业株式会社 | 2021-08-13 | — | — | CN | disclosed |
| US-20200409260-A1 | PROTECTIVE FILM FORMING COMPOSITION HAVING AN ACETAL STRUCTURE | NISSAN CHEMICAL CORPORATION (JP) | 2020-12-31 | — | — | US | disclosed |
| CN-211964115-U | Mixed gas oxidation production system | 上海优合生物科技有限公司 | 2020-11-20 | — | — | CN | disclosed |
| US-20060029811-A1 | mixing a phenolic compound containing the inorganic microfine particle(SiO2) and a compound containing at least one of the glycidyl group and/or an epoxy group containing the inorganic microfine particle; fireproofing; good mechanical properties; heat resistance; automobiles, construction, electronics | NIPPON SHOKUBAI CO., LTD. (JP) | 2006-02-09 | — | — | US | disclosed |
| CN-1730548-A | Resin composition, method for producing same, and cured product | NIPPON CATALYTIC CHEM IND (JP) | 2006-02-08 | — | — | CN | disclosed |
| US-6878659-B2 | Solid catalyst component for olefin polymerization and catalyst | TOHO TITANIUM CO., LTD. (JP) | 2005-04-12 | — | — | US | disclosed |
| EP-1507829-A1 | FIRE RETARDANT RESIN COMPOSITION, METHOD OF ITS PRODUCTION, SHAPED ARTICLES COMPRISING THE SAME, AND SILICA | Nippon Shokubai Co., Ltd. (JP) | 2005-02-23 | — | — | EP | disclosed |
| US-20040072681-A1 | Solid catalyst component for olefin polymerization and catalyst | TOHO TITANIUM CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| WO-2003099934-A1 | FIRE RETARDANT RESIN COMPOSITION, METHOD OF ITS PRODUCTION, SHAPED ARTICLES COMPRISING THE SAME, AND SILICA | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-12-04 | — | — | WO | disclosed |
| EP-1260524-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | Toho Titanium Co., Ltd. (JP) | 2002-11-27 | — | — | EP | disclosed |
| US-4842983-A | PHENOLIC RESOLE MIXED WITH LIGHT SENSITIVE SUBSTANCE OR REACTED WITH QUINONE DIAZIDE SULFONYL HALIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-06-27 | — | — | US | disclosed |
| US-4732840-A | LITHOGRAPHY | FUJI PHOTO FILM CO., LTD. (JP) | 1988-03-22 | — | — | US | disclosed |
| EP-0196031-A2 | Light-sensitive compositions and light-sensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1986-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12016312-B2 | Animal models, screening methods, and treatment methods for intraocular diseases or disorders | MB, MYOC, PDE6A | GABRA1 2619/4885GABRB2 2081/4885GABRB1 2034/4885 |
| US-20220133634-A1 | SUSTAINED RELEASE SOLID DOSAGE FORMS FOR MODULATING THE COLONIC MICROBIOME | APC, SNCA, PARK7 | GABRA1 2343/4885GABRB2 2204/4885GABRB1 1983/4885 |
| US-20220015338-A1 | ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS | MB, MYOC, PDE6A | GABRA1 2619/4885GABRB2 2081/4885GABRB1 2034/4885 |
| US-11236082-B2 | EZH2 inhibitors and uses thereof | EZH2, EZH1, BMI1 | GABRA1 3067/4885GABRB2 2512/4885GABRB1 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.